Discontinued — last reported Q4 '22

Products & Services · Total Revenue

Collaboration revenue — Total Revenue

Moderna Collaboration revenue — Total Revenue increased by 190.0% to $290.00M in Q4 2022 compared to the prior quarter. Year-over-year, this metric grew by 1971.4%, from $14.00M to $290.00M. This is a positive signal — higher values indicate stronger performance for this metric.

Analysis

StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityVolatile
First reportedQ1 2016
Last reportedQ4 2022Feb 24, 2023
Rolls up toTotal Revenue

How to read this metric

An increase reflects successful achievement of research milestones or strong demand for the company's platform technology by partners.

Detailed definition

This is the total revenue recognized from collaboration arrangements during the reporting period, derived from milestone...

Peer comparison

Standard metric across the biotech industry; peers report this as 'Collaboration Revenue' or 'License and Collaboration Revenue'.

Metric ID: mrna_segment_collaboration_revenue_total_revenue

Historical Data

7 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22
Value$18.00M$19.00M$14.00M$15.00M$35.00M$100.00M$290.00M
QoQ Change+5.6%-26.3%+7.1%+133.3%+185.7%+190.0%
YoY Change+94.4%+426.3%>999%
Range$14.00M$290.00M
CAGR+537.9%
Avg YoY Growth+830.7%
Median YoY Growth+426.3%
Current Streak4 quarters growth

Frequently Asked Questions

What is Moderna's collaboration revenue — total revenue?
Moderna (MRNA) reported collaboration revenue — total revenue of $290.00M in Q4 2022.
How has Moderna's collaboration revenue — total revenue changed year-over-year?
Moderna's collaboration revenue — total revenue increased by 1971.4% year-over-year, from $14.00M to $290.00M.
What does collaboration revenue — total revenue mean?
Total income earned from partnership and collaboration agreements.